FR2884516B1 - Antagonistes npy, preparation et utilisations - Google Patents
Antagonistes npy, preparation et utilisationsInfo
- Publication number
- FR2884516B1 FR2884516B1 FR0503795A FR0503795A FR2884516B1 FR 2884516 B1 FR2884516 B1 FR 2884516B1 FR 0503795 A FR0503795 A FR 0503795A FR 0503795 A FR0503795 A FR 0503795A FR 2884516 B1 FR2884516 B1 FR 2884516B1
- Authority
- FR
- France
- Prior art keywords
- preparation
- npy antagonists
- npy
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/452—Piperidinium derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0503795A FR2884516B1 (fr) | 2005-04-15 | 2005-04-15 | Antagonistes npy, preparation et utilisations |
PCT/FR2006/000829 WO2006108965A2 (fr) | 2005-04-15 | 2006-04-14 | Antagonistes npy, preparation et utilisations |
EP06743700A EP1879887A2 (fr) | 2005-04-15 | 2006-04-14 | Antagonistes npy, preparation et utilisations |
NI200700260A NI200700260A (es) | 2005-04-15 | 2006-04-14 | Antagonistas de npy, preparación y usos. |
AU2006234413A AU2006234413A1 (en) | 2005-04-15 | 2006-04-14 | NPY antagonists, preparation and use |
KR1020077026216A KR20080009112A (ko) | 2005-04-15 | 2006-04-14 | Npy 길항제, 제법 및 용도 |
US11/918,470 US20090233910A1 (en) | 2005-04-15 | 2006-04-14 | Npy antagonists, preparation and uses |
CNA2006800212757A CN101198604A (zh) | 2005-04-15 | 2006-04-14 | Npy拮抗剂、及其制备和应用 |
JP2008505929A JP2008538749A (ja) | 2005-04-15 | 2006-04-14 | Npy拮抗物質、調製および使用 |
CA002604773A CA2604773A1 (fr) | 2005-04-15 | 2006-04-14 | Antagonistes npy, preparation et utilisations |
AP2007004218A AP2007004218A0 (en) | 2005-04-15 | 2006-04-14 | NPY antagonists, preparation and use |
EA200800157A EA200800157A1 (ru) | 2005-04-15 | 2006-04-14 | Антагонисты npy, способ их получения и применение |
MX2007012847A MX2007012847A (es) | 2005-04-15 | 2006-04-14 | Antagonistas de npy, preparacion y usos. |
TNP2007000376A TNSN07376A1 (en) | 2005-04-15 | 2007-10-05 | Npy antagonists, preparation and use |
IL186601A IL186601A0 (en) | 2005-04-15 | 2007-10-11 | Npy antagonists, preparation and use |
NO20075322A NO20075322L (no) | 2005-04-15 | 2007-10-17 | NPY antagonister, samt femstilling og anvendelse av samme |
MA30359A MA29444B1 (fr) | 2005-04-15 | 2007-11-07 | Antagonistes npy, preparation et utilisations |
CR9514A CR9514A (es) | 2005-04-15 | 2007-11-13 | Antagonistas de npy, preparacion y usos |
EC2007007894A ECSP077894A (es) | 2005-04-15 | 2007-11-13 | Antagonistas de npy, preparación y usos |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0503795A FR2884516B1 (fr) | 2005-04-15 | 2005-04-15 | Antagonistes npy, preparation et utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2884516A1 FR2884516A1 (fr) | 2006-10-20 |
FR2884516B1 true FR2884516B1 (fr) | 2007-06-22 |
Family
ID=35447654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0503795A Expired - Fee Related FR2884516B1 (fr) | 2005-04-15 | 2005-04-15 | Antagonistes npy, preparation et utilisations |
Country Status (19)
Country | Link |
---|---|
US (1) | US20090233910A1 (fr) |
EP (1) | EP1879887A2 (fr) |
JP (1) | JP2008538749A (fr) |
KR (1) | KR20080009112A (fr) |
CN (1) | CN101198604A (fr) |
AP (1) | AP2007004218A0 (fr) |
AU (1) | AU2006234413A1 (fr) |
CA (1) | CA2604773A1 (fr) |
CR (1) | CR9514A (fr) |
EA (1) | EA200800157A1 (fr) |
EC (1) | ECSP077894A (fr) |
FR (1) | FR2884516B1 (fr) |
IL (1) | IL186601A0 (fr) |
MA (1) | MA29444B1 (fr) |
MX (1) | MX2007012847A (fr) |
NI (1) | NI200700260A (fr) |
NO (1) | NO20075322L (fr) |
TN (1) | TNSN07376A1 (fr) |
WO (1) | WO2006108965A2 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR051780A1 (es) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
GB0512091D0 (en) * | 2005-06-14 | 2005-07-20 | Novartis Ag | Organic compounds |
ATE533485T1 (de) * | 2005-10-31 | 2011-12-15 | Merck Sharp & Dohme | Cetp-inhibitoren |
US7816535B2 (en) | 2006-01-25 | 2010-10-19 | Synta Pharmaceuticals Corp. | Vinyl-phenyl derivatives for inflammation and immune-related uses |
WO2008083124A1 (fr) | 2006-12-28 | 2008-07-10 | Rigel Pharmaceuticals, Inc. | Composés d'hétérocycloalkyloxybenzamide n-substitués, et procédés d'utilisation |
CA2685029A1 (fr) * | 2007-04-26 | 2008-11-06 | Avalon Pharmaceuticals | Composes polycycliques et leurs utilisations |
JP5462784B2 (ja) | 2007-04-27 | 2014-04-02 | パーデュー、ファーマ、リミテッド、パートナーシップ | Trpv1アンタゴニストとその使用 |
JP2008303155A (ja) * | 2007-06-06 | 2008-12-18 | Ube Ind Ltd | N−(ω−フルオロアルキル)環状アミン化合物の製法、並びに新規なN−(4−フルオロブチル)環状アミン化合物及びその製法 |
JP2009035537A (ja) * | 2007-07-10 | 2009-02-19 | Nippon Synthetic Chem Ind Co Ltd:The | N−置換アニリン誘導体及び1−置換インドール誘導体の製造方法 |
BRPI0919816A2 (pt) * | 2008-09-26 | 2019-09-24 | Eisai R&D Man Co Ltd | uso compostos benzoxazólicos no tratamento de malária |
JP2012508238A (ja) * | 2008-11-07 | 2012-04-05 | ハー・ルンドベック・アクチエゼルスカベット | 生物活性を有するアミド |
WO2010101246A1 (fr) * | 2009-03-05 | 2010-09-10 | 塩野義製薬株式会社 | Dérivés de la pipéridine et de la pyrrolidine dotés d'un antagonisme pour les récepteurs npy y5 |
CA2784807C (fr) | 2009-12-29 | 2021-12-14 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de kinase raf de type ii |
PT2723732T (pt) | 2011-06-22 | 2017-02-17 | Purdue Pharma Lp | Antagonistas de trpv1 incluindo substituinte di-hidroxilo e suas utilizações |
TWI589576B (zh) * | 2011-07-15 | 2017-07-01 | 諾華公司 | 氮雜-雙環二芳基醚之鹽類及製造彼等或其前驅物之方法 |
EP2807158A4 (fr) * | 2012-01-25 | 2015-11-18 | Demerx Inc | (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ène et ses dérivés |
KR102402244B1 (ko) * | 2014-05-21 | 2022-05-26 | 솔베이 스페셜티 폴리머즈 유에스에이, 엘.엘.씨. | 안정화제 화합물 |
CA2978518C (fr) | 2015-03-27 | 2023-11-21 | Nathanael S. Gray | Inhibiteurs de kinases cycline-dependantes |
TW201710251A (zh) * | 2015-05-27 | 2017-03-16 | 諾福根有限公司 | 作為抗癌藥劑之經官能化及取代之吲哚 |
EP4019515A1 (fr) | 2015-09-09 | 2022-06-29 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de kinases cycline-dépendantes |
JP2017137259A (ja) * | 2016-02-03 | 2017-08-10 | 株式会社Ihi | 有機化合物の製造方法 |
WO2017141116A1 (fr) | 2016-02-19 | 2017-08-24 | Phoenix Molecular Designs | Dérivés de carboxamide utiles en tant qu'inhibiteurs de rsk |
CN106543089A (zh) * | 2016-11-04 | 2017-03-29 | 山东铂源药业有限公司 | 一种达沙替尼中间体的合成方法 |
CN107892656A (zh) * | 2017-10-27 | 2018-04-10 | 苏州盖德精细材料有限公司 | 一种2,5‑二氨基苯乙醇的制备方法 |
WO2021055612A1 (fr) * | 2019-09-17 | 2021-03-25 | BIAL-BioTech Investments, Inc. | Imidazole carboxamides substitués et leur utilisation dans le traitement de troubles médicaux |
KR102234530B1 (ko) * | 2020-09-01 | 2021-03-31 | 대한민국 | 신규 톨트라주릴 유도체 및 이를 포함하는 쿠도아충 예방·치료를 위한 약학 조성물 |
CN115215787A (zh) * | 2021-04-19 | 2022-10-21 | 中国科学院上海药物研究所 | 生长抑素受体5拮抗剂及其用途 |
CN117003672A (zh) * | 2023-08-09 | 2023-11-07 | 湖南正量工程技术有限公司 | 一种boc-4,4'-二硝基二苯胺的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06248153A (ja) * | 1993-03-01 | 1994-09-06 | Shin Etsu Chem Co Ltd | 難燃樹脂組成物 |
SE9703414D0 (sv) * | 1997-09-23 | 1997-09-23 | Astra Ab | New compounds |
EP1086078B1 (fr) * | 1998-06-08 | 2003-02-05 | Schering Corporation | Antagonistes des recepteurs y5 neuropeptidiques |
JP2000287697A (ja) * | 1999-02-05 | 2000-10-17 | Shionogi & Co Ltd | Npy受容体親和性を有するラクトン誘導体 |
GB9910577D0 (en) * | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
DE10038007A1 (de) * | 2000-08-04 | 2002-02-14 | Bayer Ag | Neue Amino-und Amido-Diphenylether für Arzneimittel |
JP2004509108A (ja) * | 2000-09-14 | 2004-03-25 | シェーリング コーポレイション | 置換尿素神経ペプチドyy5受容体アンタゴニスト |
CN1911913A (zh) * | 2001-07-26 | 2007-02-14 | 先灵公司 | 取代脲类神经肽y y5受体拮抗剂 |
ES2292992T3 (es) * | 2002-02-28 | 2008-03-16 | F. Hoffmann-La Roche Ag | Derivados de tiazol como antagonistas del receptor npy. |
JP4374428B2 (ja) * | 2002-07-11 | 2009-12-02 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 尿素置換されたおよびウレタン置換されたアシル尿素、それらの製造方法および医薬としてのそれらの使用方法 |
US20060160834A1 (en) * | 2003-06-06 | 2006-07-20 | Fong Tung M | Combination therapy for the treatment of hypertension |
-
2005
- 2005-04-15 FR FR0503795A patent/FR2884516B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-14 EP EP06743700A patent/EP1879887A2/fr not_active Withdrawn
- 2006-04-14 CA CA002604773A patent/CA2604773A1/fr not_active Abandoned
- 2006-04-14 CN CNA2006800212757A patent/CN101198604A/zh active Pending
- 2006-04-14 KR KR1020077026216A patent/KR20080009112A/ko not_active Application Discontinuation
- 2006-04-14 US US11/918,470 patent/US20090233910A1/en not_active Abandoned
- 2006-04-14 JP JP2008505929A patent/JP2008538749A/ja active Pending
- 2006-04-14 MX MX2007012847A patent/MX2007012847A/es unknown
- 2006-04-14 AU AU2006234413A patent/AU2006234413A1/en not_active Abandoned
- 2006-04-14 AP AP2007004218A patent/AP2007004218A0/xx unknown
- 2006-04-14 NI NI200700260A patent/NI200700260A/es unknown
- 2006-04-14 EA EA200800157A patent/EA200800157A1/ru unknown
- 2006-04-14 WO PCT/FR2006/000829 patent/WO2006108965A2/fr active Application Filing
-
2007
- 2007-10-05 TN TNP2007000376A patent/TNSN07376A1/en unknown
- 2007-10-11 IL IL186601A patent/IL186601A0/en unknown
- 2007-10-17 NO NO20075322A patent/NO20075322L/no not_active Application Discontinuation
- 2007-11-07 MA MA30359A patent/MA29444B1/fr unknown
- 2007-11-13 CR CR9514A patent/CR9514A/es not_active Application Discontinuation
- 2007-11-13 EC EC2007007894A patent/ECSP077894A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2604773A1 (fr) | 2006-10-19 |
US20090233910A1 (en) | 2009-09-17 |
NO20075322L (no) | 2008-01-11 |
MA29444B1 (fr) | 2008-05-02 |
FR2884516A1 (fr) | 2006-10-20 |
WO2006108965A2 (fr) | 2006-10-19 |
MX2007012847A (es) | 2008-03-25 |
EP1879887A2 (fr) | 2008-01-23 |
KR20080009112A (ko) | 2008-01-24 |
EA200800157A1 (ru) | 2008-04-28 |
CN101198604A (zh) | 2008-06-11 |
ECSP077894A (es) | 2008-03-26 |
IL186601A0 (en) | 2008-01-20 |
WO2006108965A3 (fr) | 2007-03-29 |
JP2008538749A (ja) | 2008-11-06 |
TNSN07376A1 (en) | 2009-03-17 |
CR9514A (es) | 2008-08-26 |
AU2006234413A1 (en) | 2006-10-19 |
AP2007004218A0 (en) | 2007-10-31 |
NI200700260A (es) | 2009-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2884516B1 (fr) | Antagonistes npy, preparation et utilisations | |
NL300935I2 (nl) | guselkumab. | |
DE602005022897D1 (de) | Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen | |
DE602006000411D1 (de) | Sicherheitsflugsitz | |
NO20051199L (no) | Rorhandteringsutstyr. | |
NL1031473A1 (nl) | Cyclopentapyridine- en tetrahydrochinolinederivaten. | |
DE602005021959D1 (de) | Substituierte diazaspiroä4.5üdecanderivate und der | |
NL1031627A1 (nl) | Acylaminobicyclische heteroaromatische verbindingen en toepassingen daarvan. | |
FR2892275B1 (fr) | Poudrier. | |
NO20053362D0 (no) | Syklofuge. | |
BRPI0614413A2 (pt) | composto, e, composição farmacêutica | |
BRPI0614412A2 (pt) | composto, e, composição farmacêutica | |
NO20081069L (no) | Dynamisk, anvendelsesutvidende teknologi | |
ITRM20050271A1 (it) | Stuoia. | |
ITRN20050016U1 (it) | Struttura combinata. | |
SE0502583L (sv) | Flaskpropp | |
FI20051176A0 (fi) | Rakennus, rakenne-elementti ja menetelmät | |
ITVA20060014U1 (it) | Protezioni ginocchio-tibia / gomito-avambraccio applicabili esternamente e trasformabili, accoppiandole. | |
ES1061250Y (es) | Conjunto garrafa-tapon. | |
ES1059287Y (es) | Prendas comunicantes. | |
FI20041628A0 (fi) | Kolmiulotteinen, optinen mittausjärjestelmä | |
ES1059858Y (es) | Premarco. | |
UA12521S (uk) | Сівалка зернотукова с3-3,6а та її модифікації | |
ES1057380Y (es) | Premarco. | |
UA11934S (uk) | Мистецький знадіб |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CL | Concession to grant licences | ||
ST | Notification of lapse |
Effective date: 20101230 |